Association of Multidisciplinary Care Team Engagement With Hemoglobin A<sub>1c</sub> Among Medicaid Enrollees With Diabetes: A Doubly Robust Machine Learning Analysis
Source check: Source checked. Not independent scientific confirmation.
Finding: In a retrospective Virginia Medicaid cohort, doubly robust machine-learning analysis estimated that multidisciplinary care-team engagement was associated with a 0.30 percentage-point lower follow-up HbA1c (95% CI −0.58 to −0.01), with larger estimated reductions at higher baseline HbA1c. The observational analysis does not prove a causal treatment effect.
Technology: Doubly robust debiased machine learning estimates the engagement association and generalized random forests characterize treatment-effect heterogeneity.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Doubly robust debiased machine learning estimates the engagement association and generalized random forests characterize treatment-effect heterogeneity.
- Test and result
- The article used doubly robust debiased machine learning and generalized random forests with sensitivity analyses in a retrospective Medicaid cohort.
- Limitation / still unknown
- Association from observational data; unmeasured confounding and selection cannot be excluded.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://diabetesjournals.org/docm-care/article/doi/10.2337/doc26-0049/172412/Association-of-Multidisciplinary-Care-Team
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary full text, including Methods and Results; publication date and first result-bearing version checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.